This paper reports the cosegregation in a three generation pedigree of dominantly inherited cataract with an abnormally high level of serum ferritin. In this family, circulating L ferritin was raised in all subjects affected by cataract independently of iron overload. We suggest that a disorder of ferritin metabolism could be a new genetic disorder leading to lens opacity. Cataracthyperferritaemia syndrome could also be a new contiguous gene syndrome involving the L ferritin gene and the gene coding for the lens membrane protein (MP19), which both map to the same region of chromosome 19q.
A number of cataracts which develop during postnatal life (so-called "acquired" cataracts) can be attributed to metabolic defects which may impair lens transparency by interfering with lens metabolism. The lens opacity can be the result either directly of the disturbed lens metabolism (for example, G6PD deficiency) or the consequence of a pathologically increased or decreased serum constituent (for example, diabetes mellitus, galactosaemia, Wilson's disease). However, the metabolic disorder leading to lens opacity is still unknown in a number of cases. ' We report here a three generation pedigree in which patients affected by cataract were also found to have high serum ferritin levels without iron overload and we suggest that a disorder of ferritin metabolism could be a new genetic condition leading to cataract.
Case report This three generation family was well known to ophthalmologists for the segregation of dominantly inherited bilateral cataract of early onset (figure). High levels of circulating ferritin were detected in all subjects affected by cataract (table) after this disorder had been discovered during extensive examination of the proband (IV-2), a female patient first examined when she was 6 years old for decreased visual acuity. At and transferrin saturation was 25% (normal 20-50%). Serum ferritin concentration was checked at least 10 times and increased values ranging from 1050,g/l to 2700,g/l were found each time whereas serum iron was in the normal range (11 [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] .tmol/l). All ferritin is still a matter of debate but the use of subunit specific antibodies in the radioimmunoassay showed that, in our family, the increase in serum ferritin levels that accompanies development of cataract corresponds mostly to an increase in L rich isoferritins. The synthesis of intracellular ferritin is regulated by iron through interaction between a cytoplasmic protein called "iron regulatory factor" (IRF) and a conserved motif present in the 5' non-coding region ofall ferritin mRNAs and called "iron responsive element" (IRE). When there is limited supply of iron to the cells, the IRF is bound to IRE and represses ferritin synthesis. It is tempting to speculate that a mutation in the DNA coding for the IRE of L ferritin or in the gene coding for IRF could impair the feedback regulation of ferritin synthesis by iron, thus leading to ferritin accumulation in the cells. How this would relate to the pathogenesis of cataract is not clear but modifications of iron turnover owing to an excess of ferritin could increase the production ofreactive oxygen species and oxidative damage is known to be implicated in age related opacification of the lens.
On the other hand, the gene coding for L ferritin has been mapped to the long arm of chromosome 19 (19q13.3-19qter)6 and it is of interest to note that a gene (LIM2), coding for a major intrinsic protein of lens membrane (MP19), has also been mapped to the same region of chromosome 19 (19ql3.4).7 LIM2 could therefore be responsible for cataract in the hypothesis of a contiguous gene syndrome.
In conclusion, cataract-hyperferritinaemia syndrome could be a new genetic disorder and we suggest that serum ferritin levels should be systematically assayed in all cases of dominant cataract.
